Jigar A. Patel

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.

Jing Pan, Peng Cui, Haiming Xu, 2012, Carcinogenesis.

PREDICTORS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN METASTATIC SOLID TUMORS: REAL WORLD EVIDENCE

I. Ong, R. Pinapati, S. McIlwain, 2020 .

Differential E xpression o f S 100A2 a nd S 100A4 D uring Progression o f H uman P rostate A denocarcinoma

G. MacLennan, H. Mukhtar, Sanjay Gupta, 2003 .

Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma.

Tajamul Hussain, Hasan Mukhtar, Pingfu Fu, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma

M. Migden, Jigar A. Patel, Nader Aboul-Fettouh, 2021, Dermatology practical & conceptual.

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

Pingfu Fu, M. Resnick, G. MacLennan, 2004, Neoplasia.

Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer.

S. Hanash, K. Do, N. Sun, 2019, Cancer research.

Hereditary cancer syndromes as model systems for chemopreventive agent development.

K. Calzone, R. Lubet, Jigar A. Patel, 2016, Seminars in oncology.

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.

Marshall W. Anderson, X. Hua, C. Morrison, 2012, Carcinogenesis.

DIAGNOSIS AND PROGNOSIS BREAST CANCER USING CLASSIFICATION RULES

Jigar Patel, Jigar A. Patel, Jahanvi Joshi, 2014 .

The anatomy of the TNM for colon cancer.

Dechang Chen, D. Henson, A. Schwartz, 2017, Journal of gastrointestinal oncology.